SereNeuro Therapeutics
PrivateLast Round
Grant
May 13, 2025
Total Funding Raised
$5.02M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
SereNeuro Therapeutics is a biotechnology company developing non-opioid cell and gene therapies for chronic pain management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SereNeuro Therapeutics Comparables
Compare SereNeuro Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genascence Corporation | 81% | |
| Adolore Biotherapeutics, Inc. | 74% | |
| Petalouda Therapeutics | 72% | |
SereNeuro Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 13, 2025 | ||||
| Seed | Feb 28, 2025 | ||||
| Grant | Nov 20, 2023 |
SereNeuro Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Johns Hopkins Technology Ventures | Grant |
| Maryland Stem Cell Research Fund | Grant |
| Ecphora Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 143% MoM, reaching 2.3K.
- May 13, 2025
Received funding from the Maryland Stem Cell Research Fund.
SereNeuro Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SereNeuro Therapeutics's valuation, stock price, and market status.